Oesophagogastric Flashcards

1
Q

Right hemithorax (draw)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Left hemithorax (draw)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Structures in the transpyloric plane

A
  • imaginary axial plane located midway between the jugular notch and superior border of pubic symphysis
  • At approximately the level of L1 vertebral body. It an important landmark as many key structures are visualised at this level, although natrurally there is anatomical variation. The structures traditionally thought of as lying in the transpyloric plane include:
  • pylorus of the stomach
  • D1 part of the duodenum
  • duodeno-jejunal flexure
  • root of the transverse mesocolon
  • hepatic flexure of the colon
  • splenic flexure of the colon
  • fundus of the gallbladder
  • neck of the pancreas
  • hila of the kidneys
  • hilum of the spleen
  • ninth costal cartilage
  • termination of spinal cord and superior portion of conus medullaris
  • origin of superior mesenteric artery
  • splenic vein joins superior mesenteric vein to form portal vein
  • cisterna chyli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Oesophagus, arterial/venous/nervous supply

A
  • Arterial supply
    • Cervical: branches of the inferior thyroid
      • Note: ligation of the ITA can be done without jepodizing the cervical oesophagoenteric anastomosis because of free anastomosis between the ITA and the STA
    • Thoracic [above carina]
      • branches of the bronchial arteries
    • Thoracic [infratracheal]
      • direct oesophageal branches of the aorta
    • Abdominal: left gastric
      • Note: there is a rich network of anastomosis intramural in distal oesophagus that communicates with the proximal stomach, thus the distal 4-5cm can be mobilized without ischaemia
    • Note:
      • There are two reasons why there isn’t much bleeding around the mobilization of the oesophagus
        • 1. Oesophageal arteries tend to be small and numerous
        • 2. They arborise into even small branches close to the wall**​​​
  • Venous supply
    • Upper 1/3: brachiocephalic veins
    • Middle 1/3: azygos system
    • Lower 1/3: left gastric
    • Lower part of the Oesophagus: Portosystemic submucosal anastomosis between portal and systemic venous systems at level of T8 (above the level of diaphragm) – read varices – between the oesophageal veins of the ayzgos (systemic) and the left gastric (portal) . Note: There is a plexus of veins in the region of the distal 5cm of oesophagus in the lamina propria , this is the site of varices?
  • Nerve supply
    • Intrinsic and extrinsic
      • Intrinsic being the myenteric and submucosal plexus throughout the GIT
      • Extrinsic supply:
        • Skeletal muscle
          • RLN
        • Smooth muscle
          • Parasympathetic from the vagus nerves and its plexi
  • Sympathetic from the sympathetic trunk, its ganglia and the greater/lesser splanchnic nerves
  • Parasympathetic from vagus and its plexuses (LA RP)
    • Afferent fibres go to nucleus of the tractus solitarius
    • Efferent fibres come from nucleus ambiguous (skeletal upper) and dorsal motor nucleus (smooth lower)
  • Sympathetic
    • Cervical (run with ITA) – Middle cervical ganglion
      • Note: Thoracic trunk begins at T1 ganglion which is fused with the inferior cervical ganglion to form the stellate ganglion
    • Thoracic sympathetic trunk and ganglia + splanchnic nerves
    • Greater and lesser splanchnic nerves?
      • Note: In order to be sure that the splanchnic nerves are fully divided in cases of chronic abdominal pain, it is necessary to remove thoracic ganglia 4-12 bilaterally.
  • Neck
    • Sympathetic
      • Middle cervical ganglion with fibres traveling with the ITA
    • Parasympathetic
      • Recurrent Laryngeal Nerve
  • Thorax
    • Sympathetic
      • Upper 4 thoracic sympathetic ganglia
    • Parasympathetic

Oesophageal plexus formed by the left and right vagus, left contributing more anteriorly and right contributing posteriorly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Definition of the gastrooesophageal junction

A
  • End of the tubular oesophagus
  • Proximal extent of the gastric folds
  • Distal extent of palisade vessels in the distal oesophagus
  • On resection specimen – proximal extent of gastric peritoneal refection
  • Other differentiating markers of oesophagus histological
    • Stratified squamous epithelium
    • Oesophageal glands in submucosal location but connecting with the lumen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Physiology of swallowing

A
  • The act of swallowing is divided into three phases:
    • Oral preparatory and transit phase
    • Pharyngeal phase
    • Oesophageal phase.
  • The upper and lower sphincters relax
  • Bolus is propelled to the stomach by peristalsis (sequential contraction of the oesophageal body, in both longitudinal and circular layers, without torque)
  • Primary peristalsis
    • Instigated centrally in the brainstem swallowing centre, with an excitatory wave arising in the pharynx and stimulating the normally atonic oesophagus
    • Transmitted via the vagus, and modulated locally (via myogenic and neuronal mechanisms)
    • Vagal efferents from the nucleus ambiguous innervate skeletal muscle, and those from the dorsomotor nucleus innervate smooth muscle, both via intrinsic neurones of the myenteric plexus, between the muscle layers.
  • A persistent bolus distends the oesophagus and its stretch receptors, triggering local neural mechanisms and a secondary peristaltic wave
    • The oesophageal latency period describes a variable period of membrane hyperpolarisation, primarily mediated by intrinsic nitric oxide inhibition. The degree of inhibition increases progressively along the oesophageal body, and contributes to deglutitive inhibition, a refractory period affecting the oesophageal body.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti reflux mechanisms

A
  • Intrinsic oesophageal mechanism
    • Lower oesophageal sphincter
      • Not an anatomically discrete sphincter
      • Dynamic HPZ in the distal oesophagus, which relaxes to allow swallowing, belching and vomiting, and constricts to prevent reflux. It is composed of specialised smooth muscle, arranged in either clasp or sling formation, running in the distal 2–4 cm of the oesophagus and cardia.
      • Basal tone
      • Adaptive pressure changes
    • Intrinsic epithelial resistance
    • Acid clearance
  • Extrinsic mechanisms
    • Diaphragmatic sphincter - slings of the right crus constitute a ‘pinchcock’ mechanism
    • Distal oesophageal compression
      • The phreno-oesophageal ligament is a prolongation of abdominal fascia originating from the abdominal surface of the diaphragm, and anchors the oesophagus,
      • This helps by keeping it in the intraabdominal higher pressure allowing the distal oesophagus to be compressed
    • Angle of His - functioning as a ‘flap-valve’
    • Mucosal rosette
  • Oesophageal protective factors
    • Pre epithelial
      • Salvia to raise pH to stop pepsinogen activation
    • Epithelial
      • Protective transmural electrochemical gradient
      • Tight cell junctions
      • pH-dependent cation channels and intracellular
    • Post epithelial
      • adaptive perfusion and epithelial repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Draw anatomy of Zenkers diverticulum

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oesophagectomy (2 stage)

A
  • Mid/lower (25cm+) oesophagus
    • Ivor Lewis
      • Phase 1 - Abdomen
        • Gastric mobilization preserving RGE
        • Kocherisation (to allow the mobility)
        • Pyloromyomyotomy (because the vagus nerves divided)
        • Divide LGA and short gastrics (to mobilise conduit length)
        • Tubularisation of stomach
        • Feeding jejunostomy
        • Need 1mm clearance, of tumour take cuff of crura
      • Phase 2 – Thorax
        • Dissection of Oesophagus
        • Division of Azygos
        • Lymphadenectomy
          • Enblock azygos and thoracic duct?
          • Cost take inferior mediastinal, subcarcal and upper abdominal (1,2,3a,7,8a, 11p)
        • Gastric pull up
        • Oesophagectomy
        • Anastomosis
        • Drains
  • Complications
    • Anastomotic leak
      • 5-10%
      • 3% require intervention
    • Conduit necrosis 1%
      • Emergency resection and delayed reconstruction
    • Pneumonia 15-30%
    • AF and cardiac
    • RLN palsy
    • Chyle leak 5%
    • Tracheooesophageal fistula 1%
    • Diagphragmatic hernias
    • GOO
    • Benign stricture
    • Death 3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Definition of Gastroesophageal reflux disease

A
  • Montreal consensus
  • “A condition when;
    • reflux of stomach contents
    • cause symptoms or complications”,
    • >2 HB (retrosternal pain/burning) episodes per week, regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Endoscopic grading of oesophagitis

A
  • Oesophagitis LA classification
      1. Is the patch confined to the top of mucosal folds (the longitudinal ridges of mucosa)?
        * Yes – A or B
          1. Is the longest patch longer than 5mm?
            * No – A
            * Yes – B
            • No - C or D
          1. Is the patch greater than 75% of the circumference of the oesophagus?
            * No – C
            * Yes – D
  • A <5mm but confined to top of mucosal fold
  • B >5mm but confined to top of mucosal fold
  • C Not confined to the top of mucosal fold but <75% circumference
  • D Not confined to mucosal fold and >75% circumference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ambulatory pH Study for GERD + scroing systom

A
  • Ambulatory pH study
    • Off PPI therapy
    • Push button when having symptoms and compare with pH
    • Indication
      • Symptoms refractory to PPI
      • Atypical symptoms and considering reflux surgery
    • Symptom severity index score
    • De meester Score
      • If more than 50% of episodes of pain correlate with a low pH then may benefit from surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hiatus hernia classifications

A
  • 1; sliding hiatus hernia, cardia and GOJ
  • 2; rare, true paraoesophageal hernia, GOJ remains intraabdominal but fundus herniates
  • 3; 1+2, GOJ and cardia into thorax + fundus
  • 4; Other organs in the sac
  • Giant hiatus hernia; type 3 or 4, at least half stomach in the thorax or hiatus >5cm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hiatus hernia triad

A

epigastric pain, retching, failed NGT

Bochdalek triad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classification of acute gastric volvulus

A
  • Classification
    • Oranoaxial (adults with HH)
      • Stomach rotates around a line drawn along the longitudinal axis from the GOJ to pylorus, associated with strangulation
    • Mesentericoaxial (congential HH)
      • Stomach rotates around a transverse axis, a line drawn across the mid lesser to mid greater curve, associated with obstructive symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Congenital diaphragmatic hernias

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pathophysiology of Achalasia

A
  • Inflammatory infiltrate at the level of the myenteric plexus leading to progressive neuronal loss, and the subsequent loss of peristalsis and incomplete/non LOS relaxation
  • Progressive oesophageal dilatation and wall thickening
    • Increased risk of oesophageal cancer (both squamous and adenocarcinoma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is pseudoachalasia?

A
  • Definition: Dilation of the oesophagus due to obstruction at the GOJ
    • Causes
      • Cancer
      • Iatrogenic
      • Chagas’ disease, an infection with Trypanosoma cruzi occurring in South America, can cause cardiomyopathy, an achalasia-like disease of the oesophagus, and mega-colon.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is hypertensive lower opesopahgeal sphincter?

A
  • >45mmhg pressure, normal relaxation and peristalsis
  • Management botox, balloon or LHM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is diffuse oesophageal spasm and how is it managed?

A
  • Not fixed by surgery
  • Rare condition
  • Presents with
    • dysphagia
    • sometimes chest pain. Chest pain is not as frequent in these patients as is often thought.
    • Self-limiting nature of their symptoms.
  • The classical appearance on a contrast swallow is that of a cork-screw oesophagus, although this is neither sensitive nor specific for the diagnosis (60%)
  • HRM shows premature contractions (shortened distal latency) similar to type III achalasia, with the important difference being that the LOS relaxes appropriately during the swallow
  • pH or impedance study is important in these patients as underlying gastro-oesophageal reflux may be the actual trigger of symptoms
  • A significant proportion of patients can be reassured and their symptoms managed with dietary modification and simple analgesia
  • Medications that relax the oesophageal muscular layers, such as nitrates, calcium channel blockers, sildenafil, or occasionally endoscopic botulinum toxin injections to the oesophagus itself (rather than the LOS as in achalasia)
  • Can consider long myotomy based on HRM ?POEM– poor evidence around this due to rarity. Probably bad.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is jackhammer/nutcracker oesophagus?

A
  • hypercontracting oesophagus along its length with normal peristalsis, 20% with DCI >8000mmhg, cause?
  • Treatment
    • Control GORD
    • Peppermint oil
    • Calcium channel blocker
    • TCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is CREST?

A

Calcinosis(skin thickening and calcium nodules)
Raynauds (vasoconstriction of the small vessels hands feet
Esophageal dysmotility
Sclerodactyly (thickeningof skin fingers)
Telangectasia (dilated capillarys of the skin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Is Zenkers diverticulum true or false?

A
  • A sac like outpouching of the oesophageal mucosa and submucosa through Killen’s triangle (false diverticulum)
  • Potential gap or weak area of the pharyngeal wall between the oblique fibres of the inferior constrictor muscle and the horizontal fibers of the cricopharyngeus muscle
  • Loss of tissue elasticity and muscle tone with age
  • As the diverticulum enlarges, the left posterolateral aspect into the mediastinum in the prevertebral plane
  • High pressure forces due to UES spasticity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

definition of Barretts oesophagus

A
  • Metaplastic replacement of the stratified squamous of the oesophagus by columnar epithelium with goblet cells in tubular oesophagus
  • salmon coloured tongues of mucosa which extend proximally from the GOJ (top of the gastric folds and end of the palisade vessels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Endoscopic grading of Barretts

A
  • Endoscopic appearance
    • Prague classification
    • Seattle protocol
      • 4 quadrants, 2cm intervals if no previous dysplasia,
      • if dysplasia then 1cm intervals, any dodgy bits then do targeted as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Management of Barretts histology

A
  • Short segment <3cm, no dysplasia
    • Repeat OGD 3-5 years, if no metaplasia?dysplasia? then d/c
  • 3+cm, no dysplasia
    • Repeat 2-3 years
  • Indefinite for dysplasia
    • PPI then repeat gastroscopy in 3 months with results reviewed by specialist histopathologist
  • Low grade dysplasia
    • Confirmed by specialist, persistent after PPI treatment
    • Recommended for treatment, then intensive surveilence as per seattle protocol
  • High grade dysplasia
    • Intramucosal carcinoma  refer to MDT UGI CENTRE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Management options for Barretts

A
  • PPI
    • Doesn’t prevent cancer but makes histology clearer
    • Treat symptoms
  • Treat GORD
  • Risk reduction (note that patients with Barrett’s but no dysplasia are more likely to die from CVS disease)
    • Smoking
    • Obesity
    • Alcohol
  • Endoscopic management
    • RFA/HALO
      • Coiled electrode that ablates the epithelium and makes a neosquamous lining
      • No evidence for non dysplastic barretts
      • No pathology specimen (so if high grade this should be excised)
      • Repeat OGD 12 weeks
      • Low grade; Ablation, risk of adeno 26->1.5%
    • Endoscopic mucosal resection
      • High grade and T1a oesophageal cancer
        • Resect the area, big biopsy
      • Contraindication
        • Circumferential, risk of perforation and stenosis
        • Ulceration
        • T1b; lymph node metastasis higher 5-50% depending
  • Oesophagectomy
    • Indication
      • T1b +
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q
A
  • 1:1000, increasing
  • Young men, history of atopy
  • Allergic reaction to food or environment
  • Dysphagia, food bolus
  • Diagnosis: symptoms, biopsy >15 eosinophils per HPF, persistent after PPI use, secondary causes need to exclude (GORD, achalasia, IBD, drug reaction, scleroderma, parasitic infection)
  • Macroscopic
    • Trachealisation Rings
    • Longitudinal furrows
    • Exudate microabscesses plaques
    • Friable/rents due to fibrotic muscle
  • Treatment
    • PPI
    • Dietary elimination
    • Topical steroids fluticasone/budesonide slurry
      • a/e thrush
    • Dilation
    • Immunologist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What does caustic mean? Whats the difference between acid and alkali oesophageal injury?

A
  • Caustic = able to burn or corrode organic tissue by chemical action
  • Alkaline
    • Sodium or potassium hydroxide (draino, disc batteries)
    • Bleach
    • Liquifactive necrosis–> denaturing proteins, saponification of adipose tissues–> not limited by tissue planes –> 3-4 days; vascular thrombosis, ulceration, necrosis–>thinning of the oesophageal wall and risk of perforation at 2 weeks, granulation and fibrosis over the next few months
  • Acidic
    • HCL acids, toilet cleaners, antirust, pool cleaners, battery fluids
    • Superficial coagulative necrosis–> thrombosis of vessels–> protective eschar
    • Acid is painful therefore less intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Grading of caustic oesophageal injury

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clinical manifestation of boerhaaves

A
  • Depends
    • Location
    • Duration
    • Degree of contamination
  • Triad (Mackler)
      1. Vomiting
      1. Pain (chest)
      1. Subcutaneous emphysema
  • Others
    • SOB
    • Chest/back/abdominal pain
    • Voice change
    • Odynophagia
    • Hammonds sign:
      • From Mediastinal gas; caused by air leak from the trachea or proximal bronchus; auscultating over the chest you can hear crepitus as the heart is beating, this is managed conservatively
  • Beware of chest pain & hypotension (perforation that has ended up wrongly in CCU)
  • Sepsis/SIRS
33
Q

Blood supply in oesophagectomy (principles)

A

Blood supply of the stomach in relation to Oesophagectomy

  • Short gastric, left gastroepiploic and left gastric are divided
    • In order to:
      • Mobilise the upper portion of the stomach so it can be pulled up to form an oesophageal substitute (conduit)
      • To allow clearance of the lesser curve lymph nodes
    • Short gastric ligated away from the greater curve to preserve the intramural network
    • The LGA is ligated flush with aorta for oncological reasons
  • Right gastroepiploic arcade.
    • This is the main blood supply and is vital to the viability of the stomach when used as an oesophageal substitute.
    • The gastrocolic omentum is opened and the entire course of the right gastroepiploic artery is carefully identified and preserved.
    • Although the arcade is complete in the majority of patients, in some it is interrupted low on the greater curvature or is only in continuity through a small branch arching away from the stomach. It is important to recognise such variations at surgery, particularly in obese patients, and dissect well away from the stomach wall to avoid compromising the arcade
34
Q

When would you consider conservative management of oesophageal perforation?

A
  • Conservative (if)
    • Contained or controlled (drains)
    • No ongoing leak on CT with oral contrast
    • No shock
    • No solid food contamination
    • No obstruction or underlying pathology
    • Intensive observation
    • MDT
    • Enternally feed (surgical jejuostomy and venting gastroscopy)
    • Low threadhold for surgical management
35
Q

How to classify location of gastroesophageal junction tumours?

A
  • Siewert classification (GOJ tumour) (5cm +/-, one is 1 above, 2 is to 2 below, 3 is from 2 below)
    • 1; Lower oesophagus 1-5cm from GOJ, may infiltrate the GOJ from above
    • 2; AT the GOJ, cannot extend >2cm into the cardia of stomach
    • 3; is a gastric cancer, 2-5cm below the GOJ and infiltrates the GOJ from below
36
Q

How to classify location of SCC oesophageal cancers?

A
  • SCC
    • Proximal 15%
    • Middle 50%
    • Distal third 35%
37
Q

Work up for oesophageal cancer?

A
  • History & examination
    • Lymph node (cervical + supraclavicular fossa)
    • Liver
    • Chest pleural effusion
  • Endoscopy
    • Lesion
      • Sessile
      • Ulcerated
      • Polypoid
      • Earlier
    • Document
      • Location
        • Proximal and distal extent
        • Landmarks
        • Hiatus hernia
      • Peristalsis absent = submucosal invasion
    • 6-8 biopsies
    • Seattle protocol of any Barretts
  • Bloods
    • CBE, EUC, LFT, CMP, baseline CEA and iron studies
  • Staging
    • CT C A P (neck?)
      • Will upstage in 15%
    • PET
      • Funded in Australia & NZ
      • Upstage 15%
      • 10-15% not PET avid
    • Diagnostic laparoscopy (lower Sievert 3)
      • Peritoneal secondaries
      • Occult liver
      • Local extent, surrounding nodes, extent of stomach disease (can it be used for a conduit still?)
      • Washings; occult peritoneal disease
    • EUS
      • Used to look at lymph nodes that are outside of standard resection field or to change management plan for fixation to aorta (not resectable) (EBUS for LN FNA)
    • Bronchscopy
      • Upper airway involvement
  • Further
    • ECG
    • Echo
    • Lung function
    • Stress
      • Echo
      • Exercise tolerance
      • Cardiopulmonary stress testing ; peak rate of oxygen uptake during exercise (VO2peak) and anaerobic threshold (AT)
    • Prehabilitation
38
Q

Chemoradiation for upper GI cancer trials

A
  • MAGIC
    • RCT pre and post chemotherapy
    • Lower oesophageal and gastric cancer
    • Phased out NOW
    • Epirubicin, 5FU and cisplatin
    • Survival benefit
  • CROSS
    • Current
    • Preoperative chemo and radiotherapy for resectable oesophageal and gastric
    • Carboplatin, paclitaxel and radiotherapy
    • Survival benefit over MAGIC
    • Neoadjuvant CROSS for all cancers that don’t go straight to resection
    • Finer details of CROSS are institutional dependent
    • Don’t give post surgery adjuvant
  • 2019 German FLOT vs MAGIC
    • 4 Preoperative and 4 postoperative 2 week cycles
    • Docetaxel , oxaliplatin, leucovorin and 5 fu vs MAGIC for T2+ Nx
    • Survival 35 vs 50 months
    • 20% improvement in survival compared to MAGIC
    • Standard of care for gastric cancer
  • TOP GEAR
    • ANZ trial, results not out yet (check prior to exam)
    • A randomised II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer
    • (FLOT maybe more responding to adenocarcinoma)
  • SCC
    • Can have definitive chemoradiotherapy or neoadjuvant depending on patient fitness
      • If fit for surgery, neoadjuvant prior to surgery
      • Borderline fitness, definitive chemoradiotherapy with salvage Oesophagectomy
    • If proximal 1/3 (compared to mid or lower) then more likely to get definitive chemoradiotherapy
    • CROSS protocol
39
Q

TNM 8th staging for oesophageal cancer adenocarcinoma

A

T4a: pericardium, pleura, peritoneum, azygos vein, diaphragm

T4b: other structures; i.e. aorta, airway, vertebrae

40
Q

Oesophageal GIST

A

Definition:

  • Mesenchymal cell tumours, thought to arise from the interstital cells of Cajal

Incidence epidemiology

Aetiology/Risk factors

Pathogenesis pathophysiology

  • CD117 C-KIT mutation (tyrosine kinase)
  • CD34
  • Mutation in KIT or PDGFRA alpha genes
  • Haematological spread

Clinical manifestations

Macroscopic features

  • Submucosal lesion
  • Can project into the lumen or be exophytic

Microfeatures

  • Classified as spindle cell, epithelioid or mixed
  • CKIT

Investigations

  • CT chest/abdo/pelvis
  • Endoscopy
  • PET
  • EUS (make sure not extrinsic compression from adjacent structure) + FNA

Treatment

  • Size, mitotic rate, symptoms, age and location
  • >2-5cm, symptomatic, high mitotic count

May need resection, given haematological spread – a formal lymphadenectomy not needed

Local resection may be sufficient

  • TKI such as imatinib control the disease for long periods
  • Discuss at MDT
41
Q

Oesophageal leiomyoma

A

Definition: Smooth muscle tumour arising from the muscularis propria or mucusalris mucosae of the oesophagus

Macroscopic appearance:

  • Submucosal lesion and normal overlying mucosa
  • Intraluminal or polypoidal tumour (if from the muscularis mucosae)
  • Middle and distal third of the oesophagus (as this is where the smooth muscle is – remember)
  • Well circumscribed, homogenous, can be annular and contrict the oesophagus

Microscopic appearance:

  • Benign spindle cells arranged in fascicles/whirls with eosinophilic cytoplasma
  • Few to no mitosis, bland nuclei and minimal cellular atypica
  • IHC positive for desmin and smooth muscle antigen (SMA), negative for CD117 and CD 34

Clinical manifestations

  • GI bleed
  • Dysphagia
  • Usually incidental

Investigations

  • Endoscopy
  • EUS (layer of origin, size, borders, regional LNs, biopsy if suspicious appearance)
  • CT chest/abdomen (invasion, extrinsic compression, relationship to oesophagus and surrounding structures)

Management

  • Asymptomatic
    • Follow up EUS in a couple months
  • If large or symptomatic
    • Removal
    • Enucleation is an option
      • VATs or Lap enucleation
      • Incision of the muscle longitudinally, split the circular muscle and use blunt dissection to dissect the tumour from the underlying mucosa, avoid damage to the mucosa i.e. perforation – this is why biopsy might weaken the muscoa and increase the risk of perforation
    • Oeosophagectomy
      • if >8-10cm
      • Annular/constrictive or multiple lesions

Prognosis

  • Can progress to a leiomyosarcoma (rapidly enlarging, invasive, lymphadenopathy), would need R0 resection and has very poor prognosis
42
Q

Oesophageal schwanoma

A

Definition:

  • These arise from the Schwannoma cells from the neural plexus in the oesophageal wall

Incidence:

  • 1-2% of alimentary tract mesenchymal tumors
  • 40-60 year olds

Pathophysiology

  • Slow growing

Macroscopic:

  • Yellow/tan rubbery appearing lesion with a glistening smooth surface
  • Upper oesophagus
  • CT homogeneous with homogeneous enhancement
  • Rare (and more likely GIST) are cystic changes, necrosis or the presence of enlarged LNs

Manifestation

  • Asymptomatic/incidental usually

Treatment

  • Asymptomatic
    • Observation
  • If large, growing, symptomatic
    • Removal
    • Enucleation
    • Partial oesophagectomy

Prognosis

  • Excellent
  • Near zero risk of malignancy
43
Q

oesophageal papilloma

A

Exophytic projections in the oesophageal lumen

Whitish/warty

Distal oesophagus

Remove with snare

Theoretical risk of cancer

Endoscopic mucosal resection and discuss at MDT (can be confused with SCC)

44
Q

Discuss nerve supply to the stomach and surgical relevance

A
  • Sympathetic
    • (which are vasomotor and also cause pyloric sphincter contraction) accompanied by afferent (pain) fibres run with the various arterial branches to the stomach, thoracic 6-9 sympathetic ganglion via the greater splanchnic
  • Parasympathetic [LARP]
    • Anterior vagal trunk
      • Arises from fibres of the oesophageal plexus from the LEFT vagus nerve which enters via the oesophageal hiatus (Usually either in anterior midline or to the RIGHT). Usually single but can be two or three.
      • Branches into the 2 divisions
        • Greater anterior gastric nerve – “Anterior nerve of Latarjet”, continues parallel to the lesser curvature in the lesser omentum, it gives off 2-12 branches to the anterior gastric wall and finishes at the antrum
        • Hepatic nerve, passes in the lesser omentum to the hilum of the liver. It gives a branch that descends to the left of the hepatic artery to the pylorus and D1. The innervation of the pylorus is from a nerve branches arose from the anterior hepatic plexus containing the branches coming from the hepatic division of vagus. The nerves ran along the right gastric artery, via the suprapyloric or supraduodenal branch, intended for the antro-pyloric region.
    • Posterior vagal trunk
      • Arises from the right vagus nerve which enters via the oesophageal hiatus usually posteriorly to the right close to the aorta
      • Divides once below the diaphragm
        • Coeliac branch that goes to the left gastric and travels back to the coeliac plexus
        • Posterior gastric nerve (posterior nerve of Latarjet)
        • Rarely the posterior gastric nerve is absent, gastric nerves to the fundus and body arise directly from the posterior TRUNK and its coeliac branches
        • Occasionally the first gastric branch arises in the hiatus or above and crosses behind the oesophagus to the left to reach the fundus. This is called the “criminal nerve of Grassi”
      • The posterior branch doesnt pylorus
  • Highly selective vagotomy;
    • Division of the anterior and posterior nerves of latarjet along the lesser curvature of the stomach, proximal to the “Crows Foot” innervation of the antrum, ~7cm proximal to prepyloric vein to 5cm above the GOJ
    • Preserve: Anterior and posterior vagal trunks including their hepatic and coeliac branches respectively. Coeliac branch innervates the rest of the fore & mid gut and the hepatic branch innervates the liver, gallbladder and pylorus
    • Pitfall: need to ensure adequate exposure of the distal oesophagus so make sure there are no posterior branches “Criminal branches of Grassi” that are going to the fundus proximally on the trunks
      *
45
Q

Embryology of the stomach

A
  • Folding of the endoderm forms the gut tube
  • Folding of the trilayered embryo
    • Foregut and hindgut get tucked in
    • while the midgut is herniated into the yolk sac
  • The stomach is a dilation of the foregut
  • Oesophagus elongates rapidly, cardia travels from C2@4weeks to T11@12weeks
  • As the primitive gut elongates there is a differential in growth between the ventral and dorsal aspect of what will become the stomach -> the stomach rotates 90 degrees to the right (longitudinal axis) and 90 degrees in AP axis
  • Stomach embryology is all about the two axis of rotation, “Rocks on its longitudinal axis and rotates”
  • The right vagus becomes the anterior trunk and the left vagus becomes the posterior trunk
  • The stomach is developed within a mesentery
    • Ventral mesogastrium becomes the lesser omentum
    • Dorsal mesogastrium becomes the greater omentum and gastrosplenic ligament
  • Dorsal mesogastrium
    • Spleen
    • Dorsal pancreatic bud
  • Ventral mesogastrium
    • Liver
    • Gallbladder
    • Bile duct
    • Ventral pancreatic bud
  • Proliferation of epithelial lining of lumen obliterates at week 6 and the central cells degenerate by week 8 allowing recanalization (note atresia, stenosis and duplications etc)
  • Germ cell layers
    • Endoderm (lines the gut tube): Epithelial lining and glands
    • Mesoderm: lamina propria, muscularis mucosae, submucosa, muscularis externa, serosa
    • Ectoderm: Enteric nervous plexus and posterior luminal digestive structures
46
Q

Lymphatic drainage of the stomach

A
  • Remember
    • lesser curve 1,3,5 greater 2,4,6,
    • 7 is left gastric artery ,
    • 8 common hepatic
    • 9 is along splenic artery
    • 10 splenic hilum
    • 12 free edge of lesser omentum (portal venous node)
  • Lymphadenectomy (not very clear)
    • D0:
    • D1: 1-7
    • D1+: D1+ 7 8 & 9
    • D2: D1+ and splenic hilum and portahepatis nodes 12, splenic 11
    • D2 modified; distal pancreatectomy and splenectomy
    • D3: paraaortic nodes
  • All lymph from the stomach eventually reaches coeliac nodes after passing through various outlying groups
  • Draw a line down the middle of the stomach in longitudinal axis, draw a line dividing the greater curve side into 1/3-2/3s
    • lymph passes to left and right gastric nodes along the left and right gastric arteries
    • upper left quadrant lymph flows via left gastroepiploic nodes and directly to pancreaticosplenic nodes at the splenic hilum, and at the upper border and posterior surface of the pancreas, accompanying the splenic artery
    • rest of the greater curvature region of the stomach lymph reaches nodes along the right gastroepiploic vessels, which drain to subpyloric nodes near the gastroduodenal artery. The pyloric part of the stomach drains to hepatic nodes in the porta hepatis and to subpyloric and right gastric nodes
  • left supraclavicular nodes may rarely become palpably involved ( Troisier’s sign ), presumably by spread along the thoracic duct.
  • The specific regional nodal areas are as follows:
    • Perigastric along the greater curvature (including greater curvature, greater omental)
    • Perigastric along the lesser curvature (including lesser curvature, lesser omental)
    • Right and left paracardial (cardioesophageal)
    • Suprapyloric (including gastroduodenal)
    • Infrapyloric (including gastroepiploic)
    • Left gastric artery
    • Celiac artery
    • Common hepatic artery
    • Hepatoduodenal (along the proper hepatic artery, including portal)
    • Splenic artery
    • Splenic hilum
  • Distant Nodal Groups = translates into a patient having metastatic disease (M1)
    • Retropancreatic
    • Pancreaticoduodenal
    • Peripancreatic
    • Superior mesenteric
    • Middle colic
    • Para-aortic
    • Retroperitoneal nodes
47
Q

Cells and glands of the stomach

A
  • Simple columnar epithelium
  • The mucosa is special because there are different types of pits and cells in various parts of the stomach
  • Cells & Glands
    • Cardia
      • Predominately mucus (to protect the oesophagus)
      • Mucous neck cells are found in the necks of the gastric pits. The mucus-secreting cells of the stomach can be distinguished histologically from the intestinal goblet cells, another type of mucus-secreting cell.
    • Fundic (oxyntic)
      • Lots of parietal and chief
      • Parietal (HCL & IF)
      • Chief (pepsinogen)
      • Fundus and body
    • Pyloric
      • Predominately mucus (to protect the duodenum)
      • G cells (gastrin)
        • Gastrin in response to protein food in the antrum  triggers HCL production by parietal cells in the body directly, and indirectly by causing histamine release by ECL cells
  • Chromaffin endocrine cells in body and pyloric region make serotonin and endorphin

Note*** the Enterochromaffin cells secrete serotonin

48
Q

Layers of the stomach

A

Layers/cells:

  • Serosa
    • Nothing special
  • Muscularis externa/propria
    • Outer longitudinal muscular coat
    • Middle circular
    • Inner oblique fibres, the oblique fibres are thickest at the notch between the oesophagus and stomach, helping to maintain this angle note only part of GI tract with three layers of muscle
  • Submucosa
    • Nothing special
  • Mucosa
    • Simple columnar epithelium
    • The mucosa is special because there are different types of pits and cells in various parts of the stomach
    • Cells
      • G cells -> Gastrin in response to protein food in the antrum -> triggers HCL production by parietal cells in the body directly, and indirectly by causing histamine release by ECL cells
    • Glands
      • Cardia
        • Predominately mucus (to protect the oesophagus)
      • Fundic
        • Lots of parietal and chief
      • Pyloric
        • Predominately mucus (to protect the duodenum)
  • G cells (gastrin producing cells) in the antrum
  • Parietal cells (HCL and IF) and peptic cells (pepsinogen) in fundus and body
  • Body, mucus secreting surface cells dip down to form gastric pits, in these there are test tube like glands that contain parietal and peptic cells
  • Chromaffin endocrine cells in body and pyloric region make serotonin and endorphin
49
Q

Draw mechanism of HCL secretion from stomach at cell level

A
50
Q

Phases of gastric secretions

A
51
Q

What do you know about h pylori

A
  • GRAM NEG ROD – spiral/curved
  • Faecal-oral route
  • Adapted to living in or beneath mucous layer of the stomach, generally not invasive
  • Renders the underlying mucosa more vulnerable to acid peptic damage by
    • Adhering to the gastric epithelium
    • Disrupting the mucous layer
    • Liberating enzymes and toxins
    • Triggers host immune response to H. pylori which further perpetuates tissue injury
  • Outcome
    • The chronic inflammation induced by H. pylori upsets gastric acid secretory physiology to varying degrees and leads to
      • Chronic gastritis which, in most individuals is asymptomatic and does not progress, or
      • Altered gastric secretion coupled with tissue injury leads to peptic ulcer disease, or
      • Gastritis progresses to atrophy, intestinal metaplasia, and eventually gastric carcinoma, or rarely
      • Persistent immune stimulation of gastric lymphoid tissue gastric lymphoma
  • Involved in 80% duodenal & 60% gastric ulcers
  • MOA
    • Increased gastrin secretion 
    • Decreased gastric mucus secretion
    • Decreases duodenal bicarbonate secretion
    • Survive in the acidic environment using flagella to get through the gastric mucus layer to be protected
    • Enzymes
      • Urease
        • Increase pH around bacteria
        • Antigenic
        • Byproducts (ammonia) are toxic to epithelium
      • Catalase
        • Antioxidant that protects pylori from ROS from activate neutrophils
      • Phospholipase
        • Disrupts mucous layer
    • Toxins
      • Releases cytotoxins that damage tissue (Vac A & Cag A)
        • Diagnosis
    • Urea breath test (urea -> labelled carbon dioxide)
    • Blood serology (past infection)
    • Faecal test (h pylori antigen)
    • Endoscopy
      • Biopsy
        • Microscopy
        • Rapid urease CLO test (pH change, urea to ammonia and carbon dioxide)
52
Q

endoscopy bleeding ulcer

A
  • F1a or b (active bleeding) - combination of adrenaline + secondary measure (clip or cautery)
  • F2a (visible vessel) - treat with or without adrenaline
  • F2b (adherent clot) - remove the clot
  • F2c or 3 (pigmented spot or clean base) - no treatment needed
53
Q

Large peptic ulcer operative mangement

A
  • Location
    • Duodenal (anterior surface D1)
  • Lavage
  • Assess
  • Repair
    • Omental patch
    • Falciform ligament
    • (Gastric) Wedge excision and biopsy
    • (Gastric) Primary closure
    • Oncological resection
    • If large
      • Antrectomy + roux en Y
      • Bancroft repair (strip distal stomach so that a distally based flap and flip back over onto the duodenum and suture it down)
    • Nissen repair (suture the anterior wall of the duodenum down to the posterior wall)
    • Close stump over a foley to create controlled fistula
  • Underlying cause
    • HP7

Gastroscopy to exclude gastric cancer

54
Q

classification on gastric cancer macro/microscopic

A

Macroscopic

  • 2 types
  • Paris classification (see picture)
    • Early classifications
      • Protruding, non protruding or excavated types
  • Boreman classification
    • Advanced lesions T2+
    • 5 different types
      • 1 protruded, polypoidal
      • 2 ulcerated with elevated borders
      • 3 ulcerated with infiltrating margins
      • 4 diffusely infiltrating
      • 5 not fitting

Microscopic

  • WHO classification of adenocarcinoma
    • Histopathological subtypes
      • Tubular (intestinal)
      • Papillary (intestinal)
      • Mucinous
      • Signet ring (diffuse)
      • Mixed
  • Lauren Classification of adenocarcinoma
    • Intestinal or diffuse – pathologically different but same treatment
    • Intestinal
      • Mass forming
      • Environmental sporadic tumour
      • Well differentiated
      • More liver metastasis risk
    • Diffuse
      • Familial and CDH1 gastric cancer
      • More ulcerating and diffuse
      • Doesn’t form a mass, infiltrative
      • Linitis plastica, non distendable stomach
      • Loss of e Cadherin molecules (similar to lobular breast cancer)
      • More prone to peritoneal disease
55
Q

Pathogenesis of gastric cancer

A
  • Correa hypothesis
    • Transformation from Normal-gastritis-atrophic gastritis (higher pH and bacterial overgrowth)- metaplasia-dysplasia-cancer
  • Genetic
    • COX2 and cyclin D2 over expression
    • P53 mutation
    • MSI
    • CDX 1 and CDX2 transcription factors
56
Q

Work up gastric cancer

A
  • Investigations
    • History and examination
      • Frailty and nutrition
      • Virchow node
      • Sister mary joseph nodule at umbilical – peritoneal disease
      • Hepatomegly or jaundice
      • Krukenburg tumor is a metastatic malignancy of the ovary characterized by mucin-rich signet-ring adenocarcinoma that primarily arises from a gastrointestinal site in most cases and less commonly from other sites. Often these tumors are bilateral (over 80%), given its metastatic nature with ovarian metastasis and pelvic mass
      • succussion splash
      • Blumers shelf
  • Gastroscopy
    • Location
    • Proximal and distal extent (closeness to GOJ)
    • Other findings
    • Biopsy 6-8 samples
    • Able to get beyond the obstruction
  • CT CAP IV and oral contrast
  • Laparoscopy
    • Washings, occult peritoneal disease and operative planning
    • Will change management 20%
    • If positive cytology then consider neoadjuvant and repeat washings
    • 1L in and 1L out around the tumour
  • EUS
    • T stage, could be good to biopsy out of field node? Not great at T1a-b differentiation without resection, ok for T1-2 differentiation
  • PET
    • Funded cardia and GOJ only in Australia 60-90% (diffuse and signet and mucinous are often not avid) – oesophagus yes, stomach no
    • Peritoneal disease in 50% of cases
    • Gastric cancers and linca plastica less avid
  • MRI for complementary to defining liver lesions
  • Nutritional assessment, cardiopulmonary assessment
  • Restage preop after neoadjuvant
57
Q

Gastrectomy complications

A
  • 3% 3 month mortality with gastrectomy
  • Anastomotic leak
  • Duodenal stump leak
  • Pancreatic fistula
  • Bleeding
    • Early
    • Late, pseudoanesurym splenic or left gastric
  • Dumping
    • Small frequent meals
    • Early and late
    • Late, reactive hypoglycaemia, low GI foods good
  • Vitamin B12, iron, Vitamin D
  • Reflux (bile)
58
Q

Malnournishment definition

A
  • Malnourishment definitions (ESPEN)
    • BMI<18.5
    • Unintentional >10% weight loss in past 6 months or 5% in past 3 months
    • Unintentional >5% weight loss in past 6 months (if patient BMI<20)
59
Q

Management of advanced unresectable or metastatic disease

A

Multimodality approach

  • 30%
  • Consider psychological support, early referral for palliative care input
  • Metastatic
    • Peritoneal
    • LN
    • Haematologenous liver, lung, bone
  • Treatment
    • Local therapies or systemic
    • Local
      • Palliative resection
      • Bypass
      • Stent endoscopically (beware migration)
      • Angiography or endoscopic management of bleeding
      • Radiotherapy
    • Chemotherapy
      • Poor
      • FLOT, triple is better then duo
      • Targeted therapy, trusetusamab HER2, ramaciramab veg F inhibitor
60
Q

NM 8th staging for gastric cancer

A
  • Insitu
    • Intraepithelial
      • Not through LP
    • T1
      • A: LP or MM
      • B; into submucosa
    • T2
      • Muscularis propria
    • T3
      • Subserosa without the visceral peritoneum
    • T4
      • Perforating serosa or into surrounding structures
  • N
    • N1: 1-2 regional
    • N2: 3-6 regional
    • N3: 7+ regional
    • N most important
    • Regional =
      • Perigastric nodes
      • L gastric, common hepatic, coeliac trunk, splenic hilum and splenic, hepatoduodenal nodes
  • M
    • Distant mets 1 or 0
    • Positive peritoneal cytology and omental seeding is classified as metastatic disease (M1)
61
Q

Follow up post gastric cancer

A
  • Clinical 3 monthly for 3 year, 6 monthly for 2 years
  • CEA and endoscopy??
  • 6 monthly CT for the first year then yearly CT to five years
  • Malnutrition
    • B12
    • Vitamin D
    • Iron
    • Steatorrhea from reconstruction
  • Bile reflux, if roux limb too short, need to sucrophate and Gaviscon
62
Q

Hereditary GIST ?triad

A

Carney’s triad

  • Gastric neurotric gist
    • extra adrenal paraganglioma or phaechromocytoma
    • pulmonary chondrites
63
Q

Gastric GIST

A

Definition:

  • Mesenchymal neoplasm arising from the interstitial cells of Cajal

Incidence epidemiology:

  • 1-3% of GI malignancy
  • ~60 years age
  • No gender
  • True prevalence not known

Aetiology/risk factors:

  • 5% hereditary/Genetic syndromes include
    • Primary familial GIST syndrome
    • Neurofibromatosis type 1 (NF1)
    • Carney-Stratakis syndrome
    • Carney triad
      • Gastric gist
      • Extra adrenal paraganglioma or phaechromocytoma
      • pulmonary chondrites

Pathogenesis pathophysiology:

  • Arising from the interstitial cells of Cajal (pacemaker cells of the menteric plexus – therefore a mesenchymal tumour)
  • Sporadic 95%
  • 5% hereditary – neurofibromatosis 1
  • C-KIT mutation, tyrosine kinase activation without any ligand,
  • Haematogenous spread or direct spread through peritoneum or retroperitoneal
  • Rare to have lymph nodes!
  • Sites
    • Liver 60-70%
    • Peritoneum 20-60%
    • Bone 5%
    • Lung 2%

Clinical manifestations:

  • Incidental
  • Non specific bloating + early satiety
  • Pain
  • Palpable mass
  • Emergency complication
    • Bleeding
    • Obstruction
    • Perforation

Macroscopic features:

  • 50% occur in the stomach
  • Other sites; colon, small bowel and oesophagus
  • Appearance
    • Rounded lesion
    • Smooth surface
    • Sometimes a central punctum
    • Submucosal
    • Low risk
      • Homogenous
      • Regular borders
    • High risk
      • Heterogenous
      • Irregular borders

Microscopic features:

  • Submucosal mass
  • Histology:
    • 3 subtypes
    • 1; spindle cell (It refers to a cell that is tapered at both ends)
      • Most common 70%
    • 2; epithelioid (20%)
    • 3; mixed
  • Immunohistochemistry:
    • >95% c KIT positive (tyrosine kinase receptor) CD117 IHC stain
    • Positive CD34 stain 70%
    • DOG1 80%
    • 5% will have PDGFa receptor (tyrosine kinase receptor)
    • Wild type positive for BRAF

Investigations:

  • Differentials : adenocarcinoma, lymphoma, leiomyoma or leiosarcoma, ectopic pancreatic
  • Endoscopy + biopsy – difficult as submucosal
  • EUS and FNA (size, invasiveness, FNAC) if atypical features or invasive or considering neoadjuvant
  • Radiology
    • CT C/A/P with IV contrast
      • Primary tumour, size and location, solid with enhancing contrast, may have areas of central necrosis or bleeding
        • Submucosal intraluminal or can be exophytic
      • Surrounding organs
      • Distant disease
    • PET scan
      • Most will be PET avid
      • Good for checking response to medical measures
      • Better for looking at liver metastasis (over CT)
      • Not funded (is in NZ if recurrent and considering resection)
  • Staging
    • AJCC
    • T = Size
      • T1 <2cm
      • T2 2-<5
      • T3 5-10cm
      • T4 10cm+
    • N1: regional nodes
    • M1:
      • Distant LNs
      • Distant Mets
    • Mitotic rate
      • Low <5 per 50 HPFs
      • High >5 per 50 HPFs

Treatment:

  • MDT discussion
    • Conservative
    • Surgical
    • Targeted therapy

Conservative

  • Small lesions incidentally found
    • I.e. <2cm with low mitotic rate – risk is 0% for malignant disease
    • Serial endoscopy and imaging

Operative

  • Mainstay of treatment
    • 1st line
      • Low risk localized
      • No metastatic
      • Is Resectable
      • Principals
        • Negative macroscopic margin
        • Keep pseudocapsule intact – avoid rupture
        • Anatomical resection/lymphadenectomy not as important
        • Local resection
        • Avoid dissemination into the peritoneal cavity
        • If involvement of adjacent organ then should be removed enbloc
      • Gastric options
        • Wedge
        • Sleeve
        • Distal Gastrectomy
        • Total gastrectomy
        • Tumour size and involvement of other organs
  • Targeted therapy
    • Neoadjuvant
      • Indication
        • Large or locally advanced, want down staging
        • Tumour is high risk preoperatively
        • Note that GIST can get resistance to TKI
    • Adjuvant
      • High risk disease (fletcher criteria – risk of local and malignant)
    • Palliative
      • First line
      • Tyrosine kinase inhibitors (Imatinib -Glivec)
      • Blocks the signaling by the KIT or the PDFGa pathways
      • 50% 5 year survival with treatment
      • VEGF inhibitors, refractory disease
  • No role for chemotherapy or radiotherapy
  • TACE or RFA might be appropriate for liver metastasis

Prognosis:

(three very import factors – see bold)

  • 50% will have distant metastatic disease
  • Rare to have lymph node involvement
  • High risk features
    • Size
    • Mitotic index
    • Primary tumour site
      • Gastric and omental is safest compared to others
    • Perforation
    • Vascular invasion
    • cKit positive or negative
    • Fletcher criteria (risk assessment – size and mitotic count)

Follow up

  • If complete resection and low risk
    • Clinical assessment 6 month for 5 years
    • CT 6 months for 2 years then annual..
  • If locally advanced
    • CT and clinical assessment every 3 months
  • Recurrence
    • 30-40% will recur
    • 1/3 distant metastasis and 1/3 local recurrence
64
Q

GIST TNM 8th staging

A
  • AJCC
  • T = Size
    • T1 <2cm
    • T2 2-<5
    • T3 5-10cm
    • T4 10cm+
  • N1: regional nodes
  • M1:
    • Distant LNs
    • Distant Mets
  • Mitotic rate
    • Low <5 per 50 HPFs
    • High >5 per 50 HPFs
65
Q

Gastric lymphoma

A

Definition:

Incidence epidemiology:

Aetiology risk factors:

  • H pylori
  • HIV
  • Campylobacter
  • EBV
  • Immunosuppresant treatment

Pathogenesis pathophysiology:

  • GIT is the most common site of extranodal lymphoma
  • 50-70% of GI lymphoma occur in the stomach
  • 2 most common types
    • MALT
      • Related to H pylori, eradication can cause remission for 77%
      • Stomach is normally devoid of lymphatic tissue, Maltoma aggregation of active b cells such as a inflammatory trigger (i.e. h pylori), due to chronic activation can undergo transformation
      • Low grade disease
    • Diffuse B cell lymphoma

Clinical manifestations:

  • Early satiety
  • Bloating
  • Vomiting
  • Complications, perforation bleeding or obstruction
  • Lymphoma B symptoms night sweats and fatigue

Macroscopic features:

  • Ill defined thickening of the mucosa
  • Erosions Ulceration
  • Friable
  • Mass
  • Large ulcer
  • Diffuse B cell lymphoma
    • More likely to form a mass

Microscopic features:

  • Dense lymphoid infiltration (“Lymphoid epithelial lesion”) that destroys the gastric glands
  • IHC
    • Positive for CD20 & CD5
    • Negative for CD10 & CD23 and cyclin D1
  • Diffuse B cell lymphoma
    • Huge nuclear size (2x size of lymphocyte), foci of MALT associated with them, destroys gastric gland

Investigations:

  • MALT may only infiltrate the submucosa therefore need to take big deep bites multiple
  • Staging
    • Full exam including lymph nodes, liver
    • Bloods FBE EUC liver LDH HIV hepatitis B C beta 2 microglobulin
    • CT neck chest abdo pelvis
    • Bone marrow biopsy
    • Classification – modified black-ledge…. no way I will remember

Treatment:

  • MALT;
    • Stage 1
      • Conservative
      • treat H pylori
      • Repeat gastroscopy 3-6 months
      • Repeat Sampling for MALT and H pylori
      • Local radiotherapy, good prognosis
      • Subtypes including translocation 11 and 18 or BCL locus – anti BCL 10 – need chemotherapy – rituximab (anti CD 20 monoclonal antibody) – 90-100% survival
    • Stage 2
      • Treat H pylori
      • Radiation
      • Progress to chemotherapy
    • Surgery not indicated, either chemotherapy or radiotherapy
    • Bleeding, obstruction, perforation would be surgical indication
  • Diffuse B cell lymphoma
    • Chemotherapy and radiotherapy
    • Surgery in complicated local disease

Prognosis:

66
Q

Neuroendocrine tumours of the stomach

A
  • Stomach not a common site of NET
  • Neuroendocrine tumors arise from the enterochromaffin like cells of the lining of GIT
  • 6% of NET GI tract are in the stomach
  • 3 types of gastric NET
    • Type 1
      • Majority 80%
      • Small polypoid multicentric tumours
      • 63 years
      • F>M
      • Chronic atrophic gastritis and pernicious anaemia
      • 10% local lymph nodes metastasis
      • Low Ki67 index <2%
      • Treatment is local resection
      • If metastasis then ocretotides or somatostatin analogues
    • Type 2
      • MEN 1
        • Hereditary condition
        • Loss of the tumour suppressor gene MEN1 on chromosome 11p13
        • Multicentric neuroendocrine tumours of the stomach, duodenum and HOP
        • Gastrin secreting tumours that can produce Zollinger Ellison syndrome
      • Locally invasive and metastatic to lymph nodes
    • Type 3
      • Sporadic
      • Neuroendocrine carcinomas (more aggressive Ki67 and mitotic rates high)
      • Solitary
      • Middle aged men
      • Metastasis to the lymph nodes and liver
67
Q

What are incretins?

A
  • Incretin hormones are gut peptides that are secreted after nutrient intake and stimulate insulin secretion together with hyperglycaemia
  • Currently, two types of incretins have been characterized, namely glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1). Both incretins are rapidly deactivated by dipeptidyl peptidase-4 (DPP4).

Incretin mimetics act like incretin hormones and are only used to treat T2DM. They can bind to GLP-1 receptors to stimulate insulin release based on the concentration of the glucose supplied, suppress appetite, inhibit glucagon secretion, and slow down the rate of gastric emptying. Their overall effect normalizes blood glucose concentration. Another dimension to the use of incretins in diabetes management is the development of GLP-1 receptor agonists with a view to improving insulin secretion by maintaining the insulinotropic activity of GLP-1 in T2DM

68
Q

Gastric polyps

A
  • Polyps found in 6% of scopes
    • 3 most common
      • Fundic
      • Hyperplastic
      • Adenomatous
  • Fundic gland polyp
    • Definition:
      • Benign cystic hyperplastic proliferation of fundic gland
    • Epidemiology
      • Most common type in found countries with high PPI use (as opposed to hyperplastic)
    • Aetiology/risk factors:
      • PPI use
      • Polyposis syndromes (FAP, MUTYH associated polyposis, Gastric adenocarcinoma with proximal polyposis of the stomach (GAPPS)
      • Zollinger Ellison syndrome
    • Pathophysiology
      • Probably arise from proliferation and differentiation of aberrantly located proliferative cells in the stem cell compartment of the corpus epithelium
    • Clinical manifestations
      • Usually incidental
    • Macroscopic features
      • <1cm
      • Body and fundus
      • hyperemic, sessile, and have a smooth surface contour
      • NBI; Honeycomb appeance with dense vasculature (non specific and can be seen with hyperplastic polyps too)
    • Microscopic features
      • Microcysts are characteristic
      • The glandular compartment typically reveals distorted architecture with irregular gland buds, tortuous glands, or irregular stellate glandular configurations
    • Treatment
      • Risk of dysplasia is low
      • Biopsy a few to prove they are benign or leave them alone, no surveillance
  • Hyperplastic polyp
    • Definition:
      • Reactive gastric polyp composed of irregular elongate and cystic foveolae set in an edematous stroma
    • Incidence epidemiology
      • Most common type in found countries with high H pylori
    • Risk factors
      • Chronic gastritis
        • H pylori
        • Autoimmune gastritis
    • Pathogenesis pathophysiology
      • Hyperproliferative response to the injury and inflammation to the mucosal lining
    • Macroscopic features
      • Smooth, villous, can be eroded
    • Microscopic features
      • Epithelial and stromal components, usually in the antrum (esp inflammatory condition such as H pylori)
    • Investigations
      • Resect to rule out malignancy
    • Treatment
      • Will resolve if inflammation dealt with I.e. h pylori eradication
    • Prognosis
      • Dysplastic focus in >2cm polyps
      • Not part of the polyp to carcinoma sequence but is associated with other colorectal carcinomas
  • Adenomatous
    • Definition:
      • Circumscribed benign epithelial neoplasm of the stomach
      • Intestinal type adenoma
    • Incidence epidemiology
      • Rare in the stomach
    • Pathogenesis pathophysiology
      • Precusor to gastric adenocarcinoma
      • Can be associated with FAP
    • Macroscopic features
      • more likely lesser curve, solitary, well circumscribed, pedunculated or sessile,
    • Investigations
      • FAP mutation – need monitoring
    • Prognosis
      • Larger size, higher risk, >2cm 50% chance of a adenocarcinoma
  • Other polyps
    • Hamartmous
      • Peutz Jager
      • Juvenile polyposis
      • Cowden disease
69
Q

Definition of obesity

A

Definition:

  • “abnormal fat accumulation that poses a risk to health”

Classification

BMI (kg/m2)

Underweight

_<_18.49

Normal range

18.5-24.9

Overweight

_>_25

Obese

­_>_30

  • Class I

30-34.9

  • Class II (moderate)

35-39.9

  • Class III (severe/morbid)

40-49.9

  • Class IV (super)

_>_50

Asian population >27 due to higher health risks

Waist circumference:

  • Women +80cm
  • Men +94cm
70
Q

Hormonal changes post bariatric surgery

A
  • Reduce ghrelin antrum? in SG> – reduces appetite
  • Reduced glucose-dependent insulin tropic polypeptide (GIP)
  • Increase glucagon-like peptide 1 (GLP-1) – gut hormones that augment insulin release and promote pancreatic beta cell proliferation, reduces appetite, improves diabetes
  • increase PYY - increased satiety
71
Q

Expected weight loss post sleeve or RYGB

A

Total body weight reduction 20%

Excess weight loss 50%

72
Q

Complications of sleeve gastrectomy (specific to sleeve)

A
  • Sleeve leak
    • Type 1 = phlegmon
    • Type 2 = abscess
      • 2a at staple line
      • 2b lateral away from staple line
    • Type 3 = free leak/peritonitis
    • Type 4 = chronic fistula
  • Stenosis
  • Reflux
  • Sleeve dilation
73
Q

Post RYBG

A
  • Gastric remnant distension
  • Stomal stenosis
  • Marginal ulcers
  • Candy cane Roux syndrome
  • Cholelithiasis
  • Ventral incisional hernia
  • Internal hernia
  • SBO
  • Intussception
  • Short bowel syndrome
  • Dumping syndrome
  • Metabolic and nutritional derangement
  • Encephalopathy (ammonia)
  • Nephrolithiasis and renal failure
  • Change in bowel habit
  • Gastrogastric fistula
  • Weight regain
74
Q

Pathophysiology of NASH

A

Non alcoholic steatohepatitis

  • Insulin resistance and excessive fatty acid influx to the liver are two important contributing factors –> disordered lipid metabolism –> steatosis –> hepatocyte injury (lipotoxicity and cellular stresses such as oxidative stress and endoplasmic reticulum stress) –> inflammation –> various degrees of fibrosis
  • Inflammation and fibrosis are frequently triggered by various signals such as proinflammatory cytokines and chemokines, released by injured hepatocytes and activated Kupffer cells.
75
Q

Microscopic appearance of NASH

A
  • Necessary components
    • Steatosis (macro > micro; accentuated in zone 3)
    • Lobular inflammation (mixed, mild; scattered polymorphonuclear leukocytes as well as mononuclear cells)
    • Hepatocellular ballooning (most apparent near steatotic liver cells, typically in zone 3)
  • Usually present; but not necessary for diagnosis
    • Perisinusoidal fibrosis (in zone 3)
    • Hepatocellular glycogenated nuclei (in zone 1)
    • Lipogranulomas (in the lobules; of varying size, but usually small)
    • Acidophil bodies or periodic acid-Schiff-stained Kupffer cells
    • Fat cysts
  • May be present but not necessary for diagnosis
    • Mallory-Denk bodies (in ballooned hepatocytes)
    • Iron deposition (in hepatocytes or sinusoidal lining cells)
    • Megamitochondria (in hepatocytes)
  • Classfication:
    • Brunt classification (two components)
      • grading
      • staging
76
Q

Describe the duodenum

A
  • C shaped 25cm most proximal part of the small bowel
  • Best described in its 4 parts (@L1 2 3)
  • There is always something happening at the middle (i.e. the foramen of winslow, the ampulla of vater, the SMA/IMA sandwich)
  • 1st part
    • L1
    • Superior duodenum
    • 2 inches (1 + 1)
    • First inch intraperitoneal
    • Run to the right, upwards and backwards from the pylorus
    • Relations
      • Anteriorly
        • Neck of the gallbladder (think fistula)
      • Superiorly:
        • It forms the inferior inlet for the foramen of windslow
      • Posteriorly:
        • Hepatic artery
        • Portal vein
        • Bile duct
        • IVC
        • Gastroduodenal artery
    • Blood supply:
      • Supraduodenal of proximal GDA, travels above or behind the D1 to enter it posteriorly in front of the bile duct
      • Gastroduodenal; variable distance off the common hepatic artery, descends behind the pylorus but in front of the portal vein. It gives off the posterior superior PDA behind the duodenum just before it emerges in front of the pancreas where it divides into the right gastroepiploic artery and the anterior superior pancreaticoduodenal artery.
      • The inferior PDA arises from the SMA
      • Best to think of the PDA’s as a network of vessels around the head of the pancreas rather than individual arteries i.e. the head of the pancreas is encircled by an anterior and a posterior arterial arcade, the vessels of which are continuous with each other in front of and behind the pancreas. These arcades give off branches to the duodenum and the pancreatic head. Therefore it is important to avoid extensive dissection in the plan between the pancreas and the duodenum.
  • 2nd part
    • L2
    • 3 inches long
    • Descending downwards over the hilum of the right kidney
    • Entirely retroperitoneal
    • Posterior medial wall receives
      • Minor duodenal papilla
        • 8cm from the pylorus
        • Opening of the minor pancreatic duct
      • Ampulla of Vater
        • Common opening of the common bile duct and main pancreatic duct
        • Opens at the summit of the major duodenal papilla
        • Half way along the D2, 10cm from the pylorus
    • Relations
      • Anterior
        • Transverse mesocolon
          • Therefore the upper half is supracolic – touching liver
          • Lower half infracolic – touching coils of jejenum
      • Posterior
        • Right kidney hilum
      • Medial
        • Head of pancreas
  • 3rd part
    • L3
    • Picture it travelling from RIGHT to LEFT
      • Starts in the right paravertebral gutter
      • Forward climbing over the RIGHT psoas muscle with its overlying ureter and gonadals
      • Over the IVC then the AORTA to the LEFT psoas muscle with its overlying gonadals
      • It is sand wedged between the SMA anteriorly and the IMA posteriorly
      • Its upper border is in contact with the lower edge of the pancreas (remember the C shape around the HOP)
      • Anteriorly the coils of jejenum lie on it (which make sense with the SMA being anterior)
      • It is crossed by the small bowel mesentery (again think of the SMA)
  • 4th part
    • 1 inch long
    • Ascends along the left side of the aorta on the left psoas muscle and left lumbar sympathetic trunk
    • Curves forward to the duodenojejeunal flexure
    • The Flexure is suspended by the Ligament of Treitz, this is a band of connective tissue that may include skeletal muscle fibres that run from the right crus of the diaphragm to connective tissue in the coeliac trunk and smooth muscle fibres that run from there, behind the pancreas and in front of the left renal vein, to the muscle coat of the flexure
  • Blood supply
    • Generally speaking, superior and inferior pancreaticoduodenal arteries (from coeliac/GDA and the SMA), it can be mobilized medially without disrupting the blood supply
    • 1st part, superior PDA and Supraduodenal artery off GDA
    • 2nd part, coming from medially off the head of the pancreas – doesn’t affect mobilization much
    • 3rd part, coming from the uncinate process – difficult to mobilise
    • 4rd part, coming from the SMA in the leaves of the mesentery – hardest to mobilise
77
Q

What to do with the difficult duodenum?

A
  • Omental patch
  • Falciform ligament
  • (Gastric) Wedge excision and biopsy
  • (Gastric) Primary closure
  • Oncological resection
  • If large
    • Antrectomy + roux en Y
    • Bancroft repair (strip distal stomach so that a distally based flap and flip back over onto the duodenum and suture it down)
  • Nissen repair (suture the anterior wall of the duodenum down to the posterior wall)
  • Close stump over a foley
78
Q
A
79
Q

H pylori virulence

A
  • Gastrin: Increased gastrin secretion 
    • Decreased gastric mucus secretion
    • Decreases duodenal bicarbonate secretion
  • Flagella: Survive in the acidic environment using flagella to get through the gastric mucus layer to be protected
  • Enzymes
    • Urease
      • Increase pH around bacteria
      • Antigenic
      • Byproducts (ammonia) are toxic to epithelium
    • Catalase
      • Antioxidant that protects pylori from ROS from activate neutrophils
    • Phospholipase
      • Disrupts mucous layer
  • Toxins
    • Releases cytotoxins that damage tissue (Vac A & Cag A)